Orchestra BioMed dips 11%, prices $75M public offering at $5 per share (OBIO:NASDAQ)
· seekingalpha.com
Orchestra BioMed prices a $75M stock offering to fund AVIM and Virtue trials.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...